SCM
Sio Capital Management’s Gyre Therapeutics GYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-623,892
| Closed | -$2.56M | – | 70 |
|
|
2021
Q3 | $2.56M | Hold |
623,892
| – | – | 0.82% | 36 |
|
|
2021
Q2 | $2.7M | Hold |
623,892
| – | – | 0.67% | 45 |
|
|
2021
Q1 | $3.14M | Buy |
623,892
+435,178
| +231% | +$2.19M | 0.64% | 50 |
|
|
2020
Q4 | $1.19M | Sell |
188,714
-10,000
| -5% | -$63.1K | 0.24% | 74 |
|
|
2020
Q3 | $854K | Hold |
198,714
| – | – | 0.17% | 72 |
|
|
2020
Q2 | $1.17M | Sell |
198,714
-20,000
| -9% | -$117K | 0.34% | 55 |
|
|
2020
Q1 | $956K | Buy |
218,714
+14,037
| +7% | +$61.4K | 0.32% | 49 |
|
|
2019
Q4 | $1.39M | Sell |
204,677
-25,000
| -11% | -$170K | 0.33% | 44 |
|
|
2019
Q3 | $1.13M | Sell |
229,677
-284,867
| -55% | -$1.4M | 0.36% | 46 |
|
|
2019
Q2 | $3.79M | Buy |
514,544
+60,236
| +13% | +$444K | 0.91% | 36 |
|
|
2019
Q1 | $3.68M | Buy |
454,308
+162,683
| +56% | +$1.32M | 0.99% | 39 |
|
|
2018
Q4 | $2.3M | Sell |
291,625
-259,352
| -47% | -$2.05M | 0.84% | 43 |
|
|
2018
Q3 | $5.94M | Buy |
550,977
+79,529
| +17% | +$857K | 2.04% | 15 |
|
|
2018
Q2 | $5.5M | Sell |
471,448
-678,541
| -59% | -$7.92M | 3.04% | 11 |
|
|
2018
Q1 | $29.7M | Buy |
1,149,989
+947,708
| +469% | +$24.5M | 17.83% | 1 |
|
|
2017
Q4 | $2.76M | Sell |
202,281
-219,354
| -52% | -$2.99M | 1.56% | 13 |
|
|
2017
Q3 | $2.13M | Buy |
421,635
+68,463
| +19% | +$346K | 1.11% | 26 |
|
|
2017
Q2 | $1.64M | Buy |
+353,172
| New | +$1.64M | 0.78% | 27 |
|